Disclosure profile
Who’s trading AVTX?
Open AVTX on RobinhoodAvalo Therapeutics, Inc.
Every disclosed Congress and corporate-insider transaction in AVTX (Avalo Therapeutics, Inc.): 55 trades from 13 politicians and executives, each AI-scored. Updated as new filings land.
Create a free account to open trades, see the full AI breakdown, and get live alerts when AVTX is traded.
Create a free account →FilerActionAmountFiledScore
Sullivan Christopher RyanSEC Form 4—$200k2026-09-185
Sullivan Christopher RyanSEC Form 4—$179k2026-09-115
Doyle MittieSEC Form 4—$5k2026-09-014
Sullivan Christopher RyanSEC Form 4—$655k2026-08-197
Doyle MittieSEC Form 4—$13k2026-08-194
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$622k2026-08-186
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$1.4M2026-08-175
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$99k2026-08-174
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$75k2026-08-174
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-142
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-144
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-144
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-144
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-143
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-143
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-144
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-131
Doyle MittieSEC Form 4—$14k2026-08-123
Riley JenniferSEC Form 4Sell$52k2026-08-123
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$52k2026-08-114
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy$12k2026-08-104
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-073
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-08-063
Doyle MittieSEC Form 4—$13k2026-07-294
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-07-062
Doyle MittieSEC Form 4—$100k2026-07-025
Philip Ron MSEC Form 4—$1k2026-07-023
Lind Kevin RobertSEC Form 4—$17k2026-07-023
Jain RitaSEC Form 4—$16k2026-07-024
Doyle MittieSEC Form 4—$26k2026-06-255
Philip Ron MSEC Form 4——2026-06-254
Avalo Therapeutics, Inc. (AVTX)SEC 8-K——2026-06-236
Avalo Therapeutics, Inc. (AVTX)SEC 8-K——2026-06-126
VARKI PAULSEC Form 4——2026-06-123
Sullivan Christopher RyanSEC Form 4——2026-06-123
Riley JenniferSEC Form 4——2026-06-125
Doyle MittieSEC Form 4——2026-06-123
Avalo Therapeutics, Inc. (AVTX)SEC 8-K——2026-06-086
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC 13GSell—2026-06-056
Heffernan Michael ThomasSEC Form 4——2026-06-044
Lind Kevin RobertSEC Form 4——2026-06-045
Jain RitaSEC Form 4——2026-06-046
KANTOFF AARONSEC Form 4——2026-06-045
Truex SamanthaSEC Form 4——2026-06-045
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy—2026-06-025
Doyle MittieSEC Form 4——2026-06-014
NEIL GARRY ARTHURSEC Form 4——2026-05-266
Doyle MittieSEC Form 4——2026-05-266
Sullivan Christopher RyanSEC Form 4——2026-05-266
Riley JenniferSEC Form 4——2026-05-264
VARKI PAULSEC Form 4——2026-05-265
Doyle MittieSEC Form 4——2026-05-196
Sullivan Christopher RyanSEC Form 4——2026-05-117
Sullivan Christopher RyanSEC Form 4Sell—2026-05-014
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)SEC Form 144Buy—2026-04-294
Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool, not investment advice.